MedPath
FDA Approval

Pacerone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
December 23, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Amiodarone(200 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aphena Pharma Solutions - Tennessee, LLC

Aphena Pharma Solutions - Tennessee, LLC

128385585

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pacerone

Product Details

NDC Product Code
67544-570
Application Number
ANDA075135
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
May 9, 2014
Code: 976728SY6ZClass: ACTIBQuantity: 200 mg in 1 1
lactose monohydrateInactive
Code: EWQ57Q8I5XClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
sodium starch glycolate type a potatoInactive
Code: 5856J3G2A2Class: IACT
povidone, unspecifiedInactive
Code: FZ989GH94EClass: IACT
starch, cornInactive
Code: O8232NY3SJClass: IACT
stearic acidInactive
Code: 4ELV7Z65APClass: IACT
FD&C Red No. 40Inactive
Code: WZB9127XOAClass: IACT
FD&C Yellow No. 6Inactive
Code: H77VEI93A8Class: IACT
© Copyright 2025. All Rights Reserved by MedPath